Background: Medicare Part D and the U. (HRR) brand-name drug use was compared, and changes in spending were calculated if use of brand-name medicines in 1 system mirrored the additional. Results: Brand-name drug use in Medicare was 2 to 3 3 times that in the VA: 35.3% versus 12.7% for oral hypoglycemics, 50.7% versus 18.2%… Continue reading Background: Medicare Part D and the U. (HRR) brand-name drug use